ACONNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACONW
Aclarion, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.89+0.04 (+2.16%)
Close on Oct 19, 2026
- Market cap
- $4.65M
- P/E (TTM)
- –
- Dividend yield
- –
Aclarion statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | Aclarion | Industry median |
|---|---|---|
| Market Cap | $5.45M | $1.07B |
| Enterprise Value | -$10.84M | $1.35B |
| PS Ratio | 65.03 | 1.63 |
| PB Ratio | 0.32 | 3.19 |
| P/TBV Ratio | 0.35 | 4.88 |
Enterprise value
| Measure | Aclarion | Industry median |
|---|---|---|
| EV / Sales | -129.38 | 1.78 |
Income (trailing twelve months)
| Measure | Aclarion | Industry median |
|---|---|---|
| Revenue | $83.77K | $543.94M |
| Gross Profit | $18.22K | $162.51M |
| Operating Income | -$9.71M | -$1.92M |
| Pretax Income | -$9.20M | -$575.82K |
| Net Income | -$9.20M | -$1.32M |
| EBITDA | -$9.47M | -$29.24K |
Margins
| Measure | Aclarion | Industry median |
|---|---|---|
| Gross Margin | 21.8% | 32.7% |
| Operating Margin | -11592.1% | -4.46% |
| Pretax Margin | -10978.5% | 1.47% |
| Profit Margin | -10978.5% | -3.18% |
| EBITDA Margin | -11302.7% | 2.41% |
Returns
| Measure | Aclarion | Industry median |
|---|---|---|
| Return on Equity (ROE) | -59.0% | 0.49% |
| Return on Assets (ROA) | -56.1% | -3.06% |
| Return on Invested Capital (ROIC) | -746.0% | 1.25% |
| Return on Capital Employed (ROCE) | -57.1% | -2.29% |
Growth
| Measure | Aclarion | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 33.1% | 7.11% |
| Revenue Growth (3Y CAGR) | 7.80% | 10.9% |
Balance sheet
| Measure | Aclarion | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $16.29M | $47.58M |
| Net Cash (Debt) | $16.29M | $217.65K |
| Net Cash Per Share | $5.65 | $0.01 |
| Equity (Book Value) | $17.00M | $189.59M |
| Book Value Per Share | $5.90 | $3.32 |
| Tangible Book Value | $15.78M | $1.72M |
| Working Capital | $15.76M | $29.77M |
Financial position
| Measure | Aclarion | Industry median |
|---|---|---|
| Current Ratio | 16.20 | 1.41 |
| Quick Ratio | 15.73 | 0.97 |
Cash flow (trailing twelve months)
| Measure | Aclarion | Industry median |
|---|---|---|
| Operating Cash Flow | -$8.09M | $1.28M |
Efficiency
| Measure | Aclarion | Industry median |
|---|---|---|
| Asset Turnover | 0.01 | 0.83 |
| Revenue Per Employee | $7.62K | $218.24K |
| Profits Per Employee | -$836.05K | -$5.96K |
| Employee Count | 11 | 897 |
Dividends and yields
| Measure | Aclarion | Industry median |
|---|---|---|
| Earnings Yield | -168.8% | -1.25% |
| Buyback Yield | -28.8% | 0.25% |
| Shareholder Yield | -28.8% | 0.60% |
Shares
| Measure | Aclarion | Industry median |
|---|---|---|
| Shares Outstanding | 2,882,370 | 58,609,450 |
| Shares Change (YoY) | 636.1% | 2.64% |
| Shares Change (QoQ) | 0.71% | 0.29% |
| Float | 2,409,480 | 34,865,600 |
| Shares Held by Insiders | 16.4% | 16.6% |
| Shares Held by Institutions | 8.97% | 85.9% |
Taxes
| Measure | Aclarion | Industry median |
|---|---|---|
| Income Tax | $0 | $671.50K |
Scores
| Measure | Aclarion | Industry median |
|---|---|---|
| Altman Z-Score | -2.55 | 1.98 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -7.46 | -2.71 |
Calculated by StockData from Aclarion's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.